Literature DB >> 16374512

DNA-damage-responsive acetylation of pRb regulates binding to E2F-1.

Douglas Markham1, Shonagh Munro, Judith Soloway, Darran P O'Connor, Nicholas B La Thangue.   

Abstract

The pRb (retinoblastoma protein) tumour suppressor protein has a crucial role in regulating the G1- to S-phase transition, and its phosphorylation by cyclin-dependent kinases is an established and important mechanism in controlling pRb activity. In addition, the targeted acetylation of lysine (K) residues 873/874 in the carboxy-terminal region of pRb located within a cyclin-dependent kinase-docking site hinders pRb phosphorylation and thereby retains pRb in an active state of growth suppression. Here, we report that the acetylation of pRb K873/874 occurs in response to DNA damage and that acetylation regulates the interaction between the C-terminal E2F-1-specific domain of pRb and E2F-1. These results define a new role for pRb acetylation in the DNA damage signalling pathway, and suggest that the interaction between pRb and E2F-1 is controlled by DNA-damage-dependent acetylation of pRb.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374512      PMCID: PMC1369245          DOI: 10.1038/sj.embor.7400591

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  27 in total

1.  Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase.

Authors:  L Vandel; E Nicolas; O Vaute; R Ferreira; S Ait-Si-Ali; D Trouche
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.

Authors:  Shutong Yang; Christin Kuo; John E Bisi; Myung K Kim
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

3.  Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells.

Authors:  J M Darbon; M Penary; N Escalas; F Casagrande; F Goubin-Gramatica; C Baudouin; B Ducommun
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

4.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 5.  The Pezcoller lecture: cancer cell cycles revisited.

Authors:  C J Sherr
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

6.  RB-dependent S-phase response to DNA damage.

Authors:  K E Knudsen; D Booth; S Naderi; Z Sever-Chroneos; A F Fribourg; I C Hunton; J R Feramisco; J Y Wang; E S Knudsen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

Review 8.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

9.  Acetylation control of the retinoblastoma tumour-suppressor protein.

Authors:  H M Chan; M Krstic-Demonacos; L Smith; C Demonacos; N B La Thangue
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

Review 10.  E2F and cell cycle control: a double-edged sword.

Authors:  Craig Stevens; Nicholas B La Thangue
Journal:  Arch Biochem Biophys       Date:  2003-04-15       Impact factor: 4.013

View more
  34 in total

1.  DNA damage signals through differentially modified E2F1 molecules to induce apoptosis.

Authors:  Jasmyne Carnevale; Oliva Palander; Laurie A Seifried; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

2.  Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation.

Authors:  Adam Pickard; Ping-Pui Wong; Dennis J McCance
Journal:  J Cell Sci       Date:  2010-10-12       Impact factor: 5.285

3.  Methylation of the retinoblastoma tumor suppressor by SMYD2.

Authors:  Louis A Saddic; Lisandra E West; Aaron Aslanian; John R Yates; Seth M Rubin; Or Gozani; Julien Sage
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 4.  Life and death decisions by the E2F transcription factors.

Authors:  Phillip J Iaquinta; Jacqueline A Lees
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

5.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

6.  Cell cycle control by a methylation-phosphorylation switch.

Authors:  Simon M Carr; Nicholas B La Thangue
Journal:  Cell Cycle       Date:  2011-03-01       Impact factor: 4.534

7.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

Review 8.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

9.  Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes.

Authors:  Samina Alam; Craig Meyers
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Opposing regulatory roles of phosphorylation and acetylation in DNA mispair processing by thymine DNA glycosylase.

Authors:  Ryan D Mohan; David W Litchfield; Joseph Torchia; Marc Tini
Journal:  Nucleic Acids Res       Date:  2009-12-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.